Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Dodds

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Internal Medicine Journal|May 25, 2010
Increased activity and improved outcome in unrelated donor haemopoietic cell transplants for acute myeloid leukaemia in Australia, 1992-2005I Nivison-Smith, A J Dodds, H Dunckley, et al.
Leukemia|June 26, 2014
Second cancers and late mortality in Australian children treated by allogeneic HSCT for haematological malignancyA S Nelson, L J Ashton, C M Vajdic, et al.
Bone Marrow Transplantation|February 19, 2014
Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: a population-based cohort studyI A Bilmon, L J Ashton, R E Le Marsney, et al.
International Journal of Laboratory Hematology|May 29, 2018
CD200 is a useful diagnostic marker for identifying atypical chronic lymphocytic leukemia by flow cytometryY S Ting, S A B C Smith, D A Brown, et al.
British Journal of Haematology|June 19, 2001
Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemiaJ P Matthews, J F Bishop, G A Young, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Internal Medicine Journal|May 25, 2010
Increased activity and improved outcome in unrelated donor haemopoietic cell transplants for acute myeloid leukaemia in Australia, 1992-2005I Nivison-Smith, A J Dodds, H Dunckley, et al.
Leukemia|June 26, 2014
Second cancers and late mortality in Australian children treated by allogeneic HSCT for haematological malignancyA S Nelson, L J Ashton, C M Vajdic, et al.
Bone Marrow Transplantation|February 19, 2014
Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: a population-based cohort studyI A Bilmon, L J Ashton, R E Le Marsney, et al.
International Journal of Laboratory Hematology|May 29, 2018
CD200 is a useful diagnostic marker for identifying atypical chronic lymphocytic leukemia by flow cytometryY S Ting, S A B C Smith, D A Brown, et al.
British Journal of Haematology|June 19, 2001
Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemiaJ P Matthews, J F Bishop, G A Young, et al.
Pageof 4